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ABSTRACT
Squamous cell carcinomas are the most commonly diagnosed oral malignancy, accounting 
for about 90% of all malignant oral lesions. Detection of the condition at early stages is rare; as 
a result, the clinical and histological characteristics and prognosis of this tumor have not been 
extensively investigated. The objective of this study was to evaluate clinical and microscopic 
features of squamous cell carcinomas using immunohistochemical analysis and assessing 
biological markers of angiogenesis and tumor vascular activity (anti-CD31, anti-CD34, Factor 
VIII), cell proliferation (Ki-67), and loss of cell suppression (p53). Tolonium chloride 1% was 
used to determine the optimal biopsy site. Six patients seen at the Stomatology Service of a 
university hospital in Canoas, southern Brazil, with a suspected diagnosis of squamous cell 
carcinoma were analyzed. All patients were male, with a mean age of 56.6 years, and four had 
a white skin color. Lesions were detected in the tongue (4) and tonsillar pillar (2). All diagnoses 
were confi rmed by microscopy (hematoxylin-eosin staining). Immunohistochemical analysis 
revealed p53 expression in 5 of the cases, Ki-67 in 6, and anti-CD34 in 1; anti-CD31 and 
Factor VIII were not detected in any patient. Our fi ndings suggest an important contribution 
of tumor markers in the diagnosis and prognosis of these malignancies, as well as in treatment 
planning.
Keywords: Mouth neoplasms. Squamous cell carcinoma. Tolonium chloride. Biological 
markers.
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Expressão de imunomarcadores em carcinomas epidermoides 
de boca
RESUMO
O carcinoma epidermoide é a neoplasia maligna bucal mais frequentemente diagnosticada, 
correspondendo a aproximadamente 90% de todas lesões malignas bucais. Sua detecção nos 
estágios iniciais da doença é rara; como resultado, tem sido difícil avaliar o comportamento 
clínico e histológico e o prognóstico deste tumor. O objetivo deste estudo foi avaliar clínica e 
microscopicamente o carcinoma epidermoide através de análise imuno-histoquímica, avaliando 
imunomarcadores tumorais angiogênicos e de atividade vascular tumoral (anticorpos anti-
CD31, anti-CD34, Fator VIII), de proliferação celular (Ki-67) e de perda de supressão celular 
(p53). Azul de toluidina a 1% foi utilizado para determinar o local ideal da biópsia incisional. 
Foram analisados seis pacientes oriundos do Serviço de Estomatologia do hospital universitário 
localizado em Canoas, sul do Brasil, com hipótese diagnóstica de carcinoma epidermoide. Todos 
os pacientes eram do sexo masculino, com idade média de 56,6 anos, e quatro tinham pele branca. 
As lesões foram detectadas na língua (4) e no pilar amigdaliano (2). Todos os diagnósticos foram 
confi rmados por microscopia (hematoxilina-eosina). A análise imuno-histoquímica revelou 
expressão de p53 em 5 dos casos, Ki-67 em 6 e anti-CD34 em 1; anti-CD31 e Fator VIII não 
apresentaram expressividade. Nossos resultados sugerem uma contribuição importante dos 
marcadores tumorais no diagnóstico e prognóstico dessas neoplasias, bem como no planejamento 
terapêutico.
Palavras-chave: Neoplasias bucais. Carcinoma de células escamosas. Azul de toluidina. 
Marcadores biológicos. 
INTRODUCTION
Squamous cell carcinomas (SCCs) are among the malignancies most commonly 
diagnosed affecting the oral cavity, accounting for 90% of all cases of neoplasms. 
Typically, SCCs show an uncontrolled proliferation of cells on the squamous layer of 
the epithelium, where cells express various degrees of similarity with their original 
cells (1).
In addition to the clinical diffi culties involved in distinguishing between 
cancerous lesions and infl ammatory, proliferative lesions (2), an additional challenge 
is to choose the optimal biopsy site for examination in a lesion with a suspected 
diagnosis of cancer.
Toluidine blue or tolonium chloride is considered a sensitive resource in the 
early identifi cation of precancerous lesions and malignant lesions of the oropharynx 
(3,4). Its action is based on the fact that dysplasias and carcinomas in situ contain 
a higher amount of DNA and RNA when compared with perilesional epithelium; 
because toluidine blue is an acidophilic substance, it stains acid tissue components 
such as DNA and RNA. This staining agent can be used to determine the lesion site 
with the most severe degree of dysplasia based on staining intensity, thus avoiding 
false-negative diagnosis (5,6).
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Tumor markers or biological markers are macromolecules present in the tumor 
itself, in the blood, or in other biological fl uids. The presence of these markers and/
or changes in their concentrations are related with oncogenesis and the growth of 
neoplastic cells. These substances are markers of the presence of cancer, and may be 
produced by the tumor or by the body in response to the presence of tumors. They can 
be useful in the clinical management of patients with cancer, especially in diagnosis, 
pathological staging, assessment of treatment response, detection of relapse, and prognosis, 
as well as in the development of new treatment approaches (7). 
The objective of this study was to assess the expression of biological markers of 
angiogenesis and tumor vascular activity (anti-CD31, anti-CD34, and Factor VIII), of 
cell proliferation (Ki-67), and of loss of tumor suppression (p53) in patients diagnosed 
with oral SCCs, using biopsy and toluidine blue 1%.
METHODOLOGY 
This cross-sectional, prospective case study was reviewed and approved by 
the Research Ethics Committee at Universidade Luterana do Brasil (protocol no. 
CEP-ULBRA 2011-398H), located in Canoas, southern Brazil. Patients signed an 
informed consent form prior to being included in the study. 
The study was conducted at the Outpatient Stomatology Service of the university 
hospital, in collaboration with the laboratory of the pathology and cytology service 
of the same institution. Six patients with a suspected diagnosis of oral malignancy 
were selected and referred for diagnostic confi rmation by anatomopathological 
examination.
Following extraoral antiseptic procedures with chlorhexidine digluconate 2% 
and local anesthesia, patients were subjected to incisional biopsy. Optimal biopsy site 
was determined after mouth rinsing with distilled water for 1 minute to remove food 
debris and biofi lm that might be located on lesion tissue. Subsequently, the lesion 
site was rubbed for 20 seconds with gauze soaked in acetic acid 1%, followed by 
gauze soaked in toluidine blue 1% solution, for another 20 seconds. Excess staining 
agent was removed using a gauze soaked in acetic acid 1%, rubbed for 20 seconds. 
The area most intensely stained was selected for analysis (8).
Tissue specimens were obtained by removing a fragment from the site most 
intensely stained via an elliptical incision with depth and diameter of approximately 
5 mm. Subsequently, specimens were fi xed in 10% formalin in a container with a 
fi xative volume 20 times the tissue volume and sent for anatomopathological analysis. 
The incision site was sutured using Vicryl® 4-0 with simple stitches. Analgesic 
medication (dipyrone) was prescribed for 48 hours, in addition to mouth rinsing with 
chlorhexidine digluconate 0.12% twice daily for 7 days.
The material was fi rst sent for light microscopy analysis with hematoxylin-eosin 
staining in order to obtain a histopathological diagnosis and confi rm the clinical 
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suspicion of SCC. Following diagnostic confi rmation with hematoxylin-eosin staining, 
paraffi n blocks with the specimens were forwarded to an immunohistochemical 
laboratory (APC, São Paulo, SP, Brazil). The heat-induced antigen recovery method 
was used, with polymer amplifi cation and development using the brown stain of 
diaminobenzidine chromogen (DAB). Assays with a positive control for each antibody 
were used, and the expression of the following biological markers was analyzed: anti-
CD31, anti-CD34, and Factor VIII, of angiogenesis and tumor vascular activity; Ki-67, 
of tumor cell proliferation; and p53, of loss of tumor suppression. These markers were 
chosen based on the objective of assessing tumor vascular activity, angiogenesis, cell 
growth, loss of tumor suppression, and lymphatic invasion.
All the readings and interpretations of microscopic and immunohistochemical 
fi ndings were performed by one single examiner experienced in light microscopy and 
immunohistochemical analysis. The examiner was blind for the use of toluidine blue 
in the samples and was previously calibrated for the analysis of the sites of interest, 
as follows: for each sample, three analyses of the same sample were conducted at 
different time points, at 3, 10, and 14 days, so as to standardize and reproduce the 
results obtained at the fi rst analysis.
The results obtained were analyzed using descriptive statistics. Each case was 
analyzed individually in relation to its own clinical and microscopic characteristics. All 
six cases were analyzed together in relation to expression of biological markers. 
RESULTS
The clinical characteristics of patients are shown in Table 1. Table 2 and Figure 1 
show the results obtained during analysis of the expression of biological markers.
TABLE 1 – Patient characteristics.
Patient Age (years) Lesion site Lesion type Duration Substance use Skin color
Patient 1 58 Tonsillar pillar Ulcer 7 months Tobacco White
Patient 2 57 Tongue (dorsum) Ulcer 3 months Tobacco Black
Patient 3 55 Tongue (border) Ulcer 5 years Tobacco White
Patient 4 66 Tongue (dorsum and border) Ulcer 15 months
Tobacco and 
alcohol White
Patient 5 47 Tonsillar pillar Ulcer 3 years Tobacco White
Patient 6 57 Tongue (border) Ulcer 3 months Tobacco Black
All patients were male.
43Stomatos, Vol. 18, Nº 35, Jul./Dec. 2012
TABLE 2 – Expression of biological markers in each patient.
Patient p53 (D07) Ki-67 (SP6) Factor VIII (Polyclonal)
Anti-CD34 
(QBEnd/10)
Anti-CD31 
(JC70)
Patient 1 + + - - -
Patient 2 + (diffuse) + - - -
Patient 3 - + - + -
Patient 4 + (focal) + - - -
Patient 5 + (focal) + - - -
Patient 6 + (focal) + - - -
+ = expression; - = no expression.
FIGURE 1 – A) Photomicrograph showing islands of neoplastic epithelium, presence of cellular atypia and 
pleomorphism, atypical mitoses and areas of keratinization (hematoxylin-eosin; x100 magnifi cation). 
B) Immunohistochemical staining for p53 (x100 magnifi cation). C) Immunohistochemical staining 
for anti-CD34 (x100 magnifi cation).
DISCUSSION
All the cases here described showed expression of Ki-67 protein, suggesting a high 
proliferative activity in SCCs affecting the tongue and tonsillar pillar. Notwithstanding, 
there were substantial percentage differences in the expression of this marker, ranging 
from 20 to 70% across the cases. According to Vieira et al. (9), this variation is related 
to the mitotic index and consequently to cell proliferation and differentiation rates in 
the neoplasm, features that reinforce the relevance of Ki-67 for the diagnosis of cancer. 
Scholzen and Gerdes (10) and Gonzalez-Moles et al. (11) have also reported a correlation 
between cell proliferation and prognosis of several tumors, with high Ki-67 rates associated 
with tumor progression and a poor prognosis (12).
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p53 expression was positive in 5 of the cases, and only one of the lesions located in 
the tongue did not show this marker. The same patient showed a low expression (20%) of 
Ki-67. According to Esposito et al. (13), there is a positive correlation between p53 and 
Ki-67, which suggests that the loss of tumor suppression associated with p53 allows an 
uncontrolled cell proliferation, with the consequent accumulation of Ki-67.
The expression of biological marker anti-CD34 was found in only one case. However, 
the same case was not reactive to anti-CD31, Factor VIII, and p53, and showed a low 
expression of Ki-67 (20%). Guttman et al. (14) assessed the expression of anti-CD34 and 
Factor VIII and found that anti-CD34 was more reliable for tumor vascular quantifi cation 
when compared with Factor VIII. Notwithstanding, when analyzing correlations between 
our results, both markers showed similar reliability in relation to a good tumor prognosis, 
except in one case (patient 3) where anti-CD34 was positive in relation to Factor VIII. 
The absence of Factor VIII expression suggests a low probability of tumor invasion into 
the lymphatic system. According to Shpitzer et al. (15), nodal metastasis in tongue SCCs 
at early stages can be previously determined based on neovascularization, via Factor VIII 
expression, thus allowing to identify patients with a high likelihood of presenting a more 
aggressive lesion evolution.
Similarly to Factor VIII, biological marker anti-CD31 was not detected in any 
case, which may be partly explained by a better prognosis in relation to tumor histology. 
Sion-Vardy et al. (16) investigated primary laryngeal carcinomas to correlate clinical and 
pathological parameters with microvascular quantifi cation using the biological markers 
anti-CD31 and Factor VIII. The authors concluded that more invasive tumors showed a 
higher expression of these markers and that quantifi cation of the vascular network was 
the only variable with signifi cant results.
CONCLUSION
The use of biological markers is extremely useful in determining the behavior of 
oral SCCs and can be used as a predictor of prognosis in patients presenting with these 
neoplasias. 
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